ZDHHC6 and inflammatory bowel disease: In the DSS-induced colitis model, ZDHHC6 expression increased with disease progression, suggesting that elucidating the precise molecular interactions and pathways mediated by ZDHHC6-mediated palmitoylation regulation will be an important research direction for the development of IBD-targeted therapies (148).